Remivox

Anticoagulant agent indicated for the prevention of stroke and systemic embolism and for reduction of mortality in patients with nonvalvular atrial fibrillation; prevention of venous thromboembolism after major orthopedic surgery; and prevention and treatment of deep vein thrombosis and acute pulmonary embolism.

Therapeutic Area
Anticoagulant

Active Ingredient
Rivaroxavan

Line
Cardiometabolism + Medical Clinic

Pharmaceutical form
15 mg x 28 tablets
20 mg x 28 tablets

Download Leaflet Descargar